Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New LSD therapies unfolding.

Chemistry & biology - 1 Sept 2007

Kozarich John W

Abstract excerpt

NIH researchers report results of a qHTS hunt for new chemical chaperones for the treatment of Gaucher disease.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Protein Folding
Share to Mutation
Share to Drug Evaluation, Preclinical
Share to Gaucher Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glucosylceramidase

Source

Identifiers

PMID: 17884629
DOI: 10.1016/j.chembiol.2007.09.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New LSD therapies unfolding.PMID 17884629Read ↗

Drug Repurposing and Lysosomal Storage Disorders: A Trick to Treat.Semantic proximity Read ↗

Preclinical studies in Krabbe disease: A model for the investigation of novel combination therapies for lysosomal storage diseases.Semantic proximity Read ↗

Ten plus one challenges in diseases of the lysosomal system.Semantic proximity Read ↗

FDA orphan drug designations for lysosomal storage disorders – a cross sectional analysisSemantic proximity Read ↗

Progress and potential of non-inhibitory small molecule chaperones for the treatment of Gaucher disease and its implications for Parkinson disease.Semantic proximity Read ↗

Innovative Treatments for Lysosomal DiseasesSemantic proximity Read ↗

Therapeutics: a glimpse of the future.Semantic proximity Read ↗

Gaucher disease: lessons from a decade of therapy.Semantic proximity Read ↗

Evolving therapies in neuronopathic LSDs: opportunities and challenges.Semantic proximity Read ↗

Update on treatment of lysosomal storage diseases.Semantic proximity Read ↗

Lots of long COVID treatment leads, but few are provenSemantic proximity Read ↗

Therapeutic strategies to ameliorate lysosomal storage disorders--a focus on Gaucher disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.